M&T Bank
ANIP icon

M&T Bank’s ANI Pharmaceuticals ANIP Stock Holding History

M&T Bank’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,602
Closed -$472K – 1820
2015
Q2 		$472K Sell
7,602
-410
-5% -$24.4K ﹤0.01% 1245
2015
Q1 		$501K Buy
8,012
+3
+0% +$182 ﹤0.01% 1189
2014
Q4 		$452K Sell
8,009
-24,099
-75% -$1.06M ﹤0.01% 1263
2014
Q3 		$908K Buy
+32,108
New +$962K 0.01% 936

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

M&T Bank's ANIP Position: Q3 2015 in Review

M&T Bank sold out of ANI Pharmaceuticals (ANIP) in Q3 2015, closing a stake of 7,602 shares — an estimated $472K sold.

M&T Bank first reported a position in ANIP in Q3 2014 and held it in 4 quarters. The position peaked at $908K in Q3 2014. 121 funds tracked by Wall St. Rank hold ANIP as of Q3 2015.

  • M&T Bank reported no remaining ANI Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 7,602 ANI Pharmaceuticals shares in Q3 2015, an estimated $472K.
  • M&T Bank first reported a position in ANI Pharmaceuticals in Q3 2014 and held it in 4 quarters.
  • M&T Bank's ANI Pharmaceuticals position peaked at $908K in Q3 2014.
  • 121 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.